secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001493152-24-034647
Event type: debt
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma enters $85K AUD loan from board member for working capital
----------------------------------------------------------------------------

- Effective August 26, 2024, company entered loan agreement with a board member for $85,000 AUD.
- Loan has no maturity date or interest rate; repayment at company's discretion.
- Proceeds used for general working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224034647/0001493152-24-034647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224034647/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer